Preparation of amino acid conjugates of betulinic acid with activity against human melanoma.
Betulinic acid has been coupled with a series of amino acids at C-28 carboxylic acid position and the toxicity of the derivatives has been evaluated against cultured human melanoma (MEL-2) and human epidermoid carcinoma of the mouth (KB) cell lines. A number of amino acid conjugates of betulinic acid showed improved water solubility as well as selective cytotoxicity. This investigation demonstrates that amino acid conjugates of betulinic acid can produce potentially important derivatives, which may be developed as antitumor agents.
D000970:Antineoplastic Agents / Q000493:pharmacokinetics* / Q000494:pharmacology*; D005354:Fibrosarcoma / Q000188:drug therapy; D006801:Humans; D006868:Hydrolysis; D008545:Melanoma / Q000188:drug therapy*; D053978:Pentacyclic Triterpenes; D014315:Triterpenes / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D000094062:Betulinic Acid